date/time interval
- April 1, 2021 - October 31, 2023
A Phase I Trial of Tazemetostat Combined with Venetoclax in Patients with Relapsed/Refractory NHL
Grant
Overview
awarded by
administered by
sponsor award ID
- LRF 210980-01
Affiliation
contributor
- Leonard, John P Principal Investigator 2021 - 2023
- Mulvey, Erin Key Personnel 2021 - 2023